Profile

VeriLuce Therapeutics is an early-stage company currently focusing on the computational design and development of small molecule(s) targeting and antagonizing chemokine receptors within the tumor micro-environment. The intent is to slow-down/block angiogenesis and metastasis of cancer. VeriLuce’s compound(s) differentiates from other chemokine receptor antagonists by each targeting a specific ‘dual-receptors-combination’ not yet targeted by other chemokine antagonists. This differentiation could potentially provide a novel and effective ‘tumor micro-environment modulation’ to help fight cancer.

VeriLuce Therapeutics logo

Website

verilucetherapeutics.com

Contact

Event details

Date: September 14 - 16, 2020

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

16 in total
  • Artenga Inc.
    Artenga’s microbubble drug conjugates (MDC) are used with focused ultrasound (FUS) as a key…
  • Chip Care
    ChipCare is a Toronto-based pre-revenue company, developing a point-of-care platform which will have the unique…
  • CURIATO
    Curiato is pioneering a non-invasive patient monitoring platform for healthcare. Our platform relies on our smart bed…
  • Exact Imaging
    Exact Imaging is the world’s leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided…
  • KA Imaging
    KA Imaging has created color x-ray that allows for bone and soft tissue separation similar to CT, but at a fraction of…
  • Lumasonix Inc.
    The low-cost Lumasonix Blood Test (LBT) provides crucial information about otherwise undetectable cancer…
  • Mediphage Bioceuticals Inc.
    Mediphage Bioceuticals is a genetic medicine company developing safe, effective, and accessible cures for chronic and…
  • Nanology Labs
    Nanology Labs has developed a tumor modulating theranostic agent, Manganescan, with capability to oxygenate tumors and…
  • OPTT Inc.
    OPTT is a digital mental health platform equipping healthcare organizations with a comprehensive package of digital…
  • OVENSA
    Ovensa is a Canadian preclinical stage company developing a siRNA drug candidate silencing the overexpression of…
  • SaluTech
    SaluTech has developed a proprietary conductive biomaterial (CBM) to treat patients suffering from Atrial…
  • Swan Cytologics
    The SWANglide ultrasound-enhanced needle biopsy from Swan Cytologics improves patient outcomes and reduces healthcare…
  • Thornhill Medical
    Thornhill Medical is a Canadian designer and manufacturer of innovative healthcare technology. Our product portfolio…
  • Ventripoint Diagnostics
    Ventripoint Diagnostics is a medical device company engaged in the development and commercialization of a breakthrough…
  • VeriLuce Therapeutics
    VeriLuce Therapeutics is an early-stage company currently focusing on the computational design and development of small…
  • Vitreo Pharma
    Vitreo Pharma is a developmental stage company that utilizes a polypharmacology strategy to generate our lead, first-in…